Kirkland & Ellis, which closed out 2012 by topping our list of most valuable firms and poaching a prominent M&A partner from Cravath, Swaine & Moore, is getting off to a good start on the transactional front this year with a pair of deals announced Tuesday.
In one of those transactions, the Am Law 100 firm is advising pharmaceutical giant Bristol-Myers Squibb on a $482 million Latin American medicine licensing agreement with Reckitt Benckiser. In the other, the firm is representing private equity firm 3i Group in connection with its $972 million sale of Canadian plastics technology company Mold-Masters.
